semaglutide and multiple sclerosis Semaglutide, a novel glucagon-like peptide-1 agonist, amends experimental autoimmune encephalomyelitis-induced in mice: Involvement of the PI3K/Akt/GSK-3β pathway You might know them as
Description
Pharma giant Novo Nordisk is partnering with telehealth companies to expand access to its blockbuster weight loss drug Wegovy
This study aimed to assess and compare the efficacy of these GLP-1 analogs in MC4R knockout (KO) mice, which are deficient in the POMC-MC4R pathway
Alo breaks down the SELECT trial data, debunks the "muscle melting" myth with new NIH research, and shares his protocol for protecting lean mass.
So when EVOKE and EVOKE+ showed no benefit ofsemaglutide, it was disappointing but not surprising
